Atıf Formatları
Formulation and comparative bioavailability of conventional and sustained release furosemide tablets
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

F. Farshi Et Al. , "Formulation and comparative bioavailability of conventional and sustained release furosemide tablets," S.T.P. Pharma Pratiques , vol.5, no.5, pp.361-366, 1995

Farshi, F. Et Al. 1995. Formulation and comparative bioavailability of conventional and sustained release furosemide tablets. S.T.P. Pharma Pratiques , vol.5, no.5 , 361-366.

Farshi, F., ÇAPAN, Y., Kes, S., & Hincal, A., (1995). Formulation and comparative bioavailability of conventional and sustained release furosemide tablets. S.T.P. Pharma Pratiques , vol.5, no.5, 361-366.

Farshi, F.S. Et Al. "Formulation and comparative bioavailability of conventional and sustained release furosemide tablets," S.T.P. Pharma Pratiques , vol.5, no.5, 361-366, 1995

Farshi, F.S. Et Al. "Formulation and comparative bioavailability of conventional and sustained release furosemide tablets." S.T.P. Pharma Pratiques , vol.5, no.5, pp.361-366, 1995

Farshi, F. Et Al. (1995) . "Formulation and comparative bioavailability of conventional and sustained release furosemide tablets." S.T.P. Pharma Pratiques , vol.5, no.5, pp.361-366.

@article{article, author={F.S. Farshi Et Al. }, title={Formulation and comparative bioavailability of conventional and sustained release furosemide tablets}, journal={S.T.P. Pharma Pratiques}, year=1995, pages={361-366} }